Philadelphia Trust Co’s Abbott Laboratories Position
Does Philadelphia Trust Co own Abbott Laboratories (ABT)? Yes — 251.1K shares worth $26M (+1.82% of its 13F portfolio) as of Q1 2026, down from 255.0K shares the prior filed quarter.
Position Value
$26M
Q1 2026
Shares
251.1K
% of Portfolio
+1.82%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 251.1K | $26M | +1.82% |
| Q4 2025 | 255.0K | $32M | +2.20% |
| Q3 2025 | 258.7K | $35M | +2.44% |
| Q2 2025 | 266.2K | $36M | +2.78% |
| Q1 2025 | 266.6K | $35M | +3.03% |
| Q4 2024 | 289.8K | $33M | +2.40% |
| Q3 2024 | 299.3K | $34M | +2.48% |
| Q2 2024 | 287.4K | $30M | +2.32% |
| Q1 2024 | 284.5K | $32M | +2.60% |
| Q4 2023 | 279.4K | $31M | +2.89% |
| Q3 2023 | 284.8K | $28M | +2.83% |
| Q2 2023 | 293.9K | $32M | +3.03% |
| Q1 2023 | 298.0K | $30M | +3.07% |
| Q4 2022 | 306.1K | $34M | +3.60% |
| Q3 2022 | 325.6K | $32M | +3.56% |
| Q2 2022 | 329.1K | $36M | +3.67% |
| Q1 2022 | 340.9K | $40M | +3.18% |
| Q4 2021 | 349.7K | $49M | +3.56% |
| Q3 2021 | 321.7K | $38M | +2.80% |
| Q2 2021 | 383.6K | $44M | +3.07% |
| Q1 2021 | 401.8K | $48M | +3.70% |
| Q4 2020 | 410.5K | $45M | +3.66% |
| Q3 2020 | 423.7K | $46M | +4.45% |
| Q2 2020 | 417.7K | $38M | +4.02% |
| Q1 2020 | 402.2K | $32M | +4.00% |
| Q4 2019 | 417.5K | $36M | +3.11% |
| Q3 2019 | 428.0K | $36M | +3.32% |
| Q2 2019 | 471.4K | $40M | +3.49% |
| Q1 2019 | 488.9K | $39M | +3.45% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Philadelphia Trust Co’s full portfolio or all institutional holders of ABT.